Author details

Full Name

Susan G Hilsenbeck

Affiliation

ORCID

Career Start Year

1984

Papers

352

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37935320	Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System.	Am J Prev Med	2024
37501682	Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor-positive Breast Cancers for Targeted Treatment.	Cancer Res Commun	2023
37808840	Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.		2023
37562095	Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population.		2023
37874652	Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.		2023
36831684	Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated.		2023
36585450	Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.	Nat Cancer	2023
37195235	A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer.	Clin Cancer Res	2023
36627285	Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer.		2023
36469573	A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma.	Clin Cancer Res	2023
34714554	Mouse-INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy.	J Pathol	2022
36261627	STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential.	Oncogene	2022
35726868	Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium.	Pediatr Blood Cancer	2022
36619972	Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach.	iScience	2022
34667127	Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer.	Cancer Prevention Research	2022
34782721	Correction to: Hormonal modulation of ESR1 mutant metastasis.	Oncogene	2022
34470810	Correction: Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.	Clin Cancer Res	2021
33542078	Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer.	Clinical Cancer Research	2021
34045483	Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models.	npj Breast Cancer	2021
34099494	A Wnt-Independent LGR4-EGFR Signaling Axis in Cancer Metastasis.	Cancer Research	2021
34312215	A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop.	Clin Cancer Res	2021
35156101	Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics.	Cancer Res Commun	2021
31037288	HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade.	J Natl Cancer Inst	2020
32142667	Neurofibromin Is an Estrogen Receptor-Î± Transcriptional Co-repressor in Breast Cancer.	Cancer Cell	2020
32352029	BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression.	NPJ Breast Cancer	2020
32165040	Outcomes Among Minority Patients With Metastatic Colorectal Cancer in a Safety-net Health Care System.		2020
31662331	TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer.	Clin Cancer Res	2020
31653641	Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy.	Clin Cancer Res	2020
33087164	Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial.	Trials	2020
30903140	A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer.	Ann Oncol	2019
31672983	The Signaling Pathways Project, an integrated 'omics knowledgebase for mammalian cellular signaling pathways.	Sci Data	2019
32923856	Model-Assisted Designs for Early-Phase Clinical Trials: Simplicity Meets Superiority.	JCO Precision Oncology	2019
30401712	Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes.	Cancer Res	2019
30488179	A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities.	Cancer Chemotherapy and Pharmacology	2019
30482469	Exome sequencing disclosures in pediatric cancer care: Patterns of communication among oncologists, genetic counselors, and parents.	Patient Educ Couns	2019
31420371	Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer.	Mol Cancer Res	2019
31219523	Association Between Birth Defects and Cancer Risk Among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births.	JAMA Oncol	2019
31218477	Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia.	Breast Cancer Research and Treatment	2019
29778097	Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.	Breast Cancer Research	2018
28541380	A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data.	Biostatistics	2018
30537887	Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma.	Pediatr Hematol Oncol	2018
30420638	Publisher Correction: EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells.	Nat Commun	2018
29626114	Combination anti-AÎ² treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice.	J Exp Med	2018
29128193	Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27.	Clin Breast Cancer	2018
29110152	Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.	Breast Cancer Res Treat	2018
29578538	Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.	Nat Med	2018
28224382	Retrospective review of genomic testing in breast cancer: Does it improve outcome?	Breast Cancer Research and Treatment	2017
28916657	Tenascin-C and Integrin Î±9 Mediate Interactions of Prostate Cancer with the Bone Microenvironment.	Cancer Res	2017
28604738	EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells.	Nat Commun	2017
28465075	Carbon nanotube capsules enhance the in vivo efficacy of cisplatin.	Acta Biomater	2017